213 related articles for article (PubMed ID: 22772452)
1. Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses.
Wang Z; MacLeod DT; Di Nardo A
J Immunol; 2012 Aug; 189(4):1551-8. PubMed ID: 22772452
[TBL] [Abstract][Full Text] [Related]
2. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.
Wang Z; Lai Y; Bernard JJ; Macleod DT; Cogen AL; Moss B; Di Nardo A
J Immunol; 2012 Jan; 188(1):345-57. PubMed ID: 22140255
[TBL] [Abstract][Full Text] [Related]
3. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.
Di Nardo A; Yamasaki K; Dorschner RA; Lai Y; Gallo RL
J Immunol; 2008 Jun; 180(11):7565-73. PubMed ID: 18490758
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.
Domenico J; Lucas JJ; Fujita M; Gelfand EW
Int Arch Allergy Immunol; 2012; 158(2):196-205. PubMed ID: 22286752
[TBL] [Abstract][Full Text] [Related]
5. Skin microbiome promotes mast cell maturation by triggering stem cell factor production in keratinocytes.
Wang Z; Mascarenhas N; Eckmann L; Miyamoto Y; Sun X; Kawakami T; Di Nardo A
J Allergy Clin Immunol; 2017 Apr; 139(4):1205-1216.e6. PubMed ID: 27746235
[TBL] [Abstract][Full Text] [Related]
6. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands.
Mrabet-Dahbi S; Metz M; Dudeck A; Zuberbier T; Maurer M
Exp Dermatol; 2009 May; 18(5):437-44. PubMed ID: 19382314
[TBL] [Abstract][Full Text] [Related]
7. Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection.
Martinez J; Huang X; Yang Y
PLoS Pathog; 2010 Mar; 6(3):e1000811. PubMed ID: 20300608
[TBL] [Abstract][Full Text] [Related]
8. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands.
Mullaly SC; Kubes P
J Immunol; 2006 Dec; 177(11):8154-63. PubMed ID: 17114491
[TBL] [Abstract][Full Text] [Related]
9. Bacterial products increase expression of the human cathelicidin hCAP-18/LL-37 in cultured human sinus epithelial cells.
Nell MJ; Tjabringa GS; Vonk MJ; Hiemstra PS; Grote JJ
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):225-31. PubMed ID: 15364108
[TBL] [Abstract][Full Text] [Related]
10. Mast Cell Cytonemes as a Defense Mechanism against Coxiella burnetii.
Mezouar S; Vitte J; Gorvel L; Ben Amara A; Desnues B; Mege JL
mBio; 2019 Apr; 10(2):. PubMed ID: 30992359
[TBL] [Abstract][Full Text] [Related]
11. Urticaria Neonatorum: accumulation of tryptase-expressing mast cells in the skin lesions of newborns with Erythema Toxicum.
Nelson A; Ulfgren AK; Edner J; Ståbi B; Brismar H; Hultenby K; Marchini G
Pediatr Allergy Immunol; 2007 Dec; 18(8):652-8. PubMed ID: 18078419
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.
Di Nardo A; Vitiello A; Gallo RL
J Immunol; 2003 Mar; 170(5):2274-8. PubMed ID: 12594247
[TBL] [Abstract][Full Text] [Related]
13. MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.
Davies ML; Sei JJ; Siciliano NA; Xu RH; Roscoe F; Sigal LJ; Eisenlohr LC; Norbury CC
J Virol; 2014 Mar; 88(6):3557-67. PubMed ID: 24403581
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
Takeuchi O; Hoshino K; Kawai T; Sanjo H; Takada H; Ogawa T; Takeda K; Akira S
Immunity; 1999 Oct; 11(4):443-51. PubMed ID: 10549626
[TBL] [Abstract][Full Text] [Related]
15. New insights into the antimicrobial effect of mast cells against Enterococcus faecalis.
Scheb-Wetzel M; Rohde M; Bravo A; Goldmann O
Infect Immun; 2014 Nov; 82(11):4496-507. PubMed ID: 25114115
[TBL] [Abstract][Full Text] [Related]
16. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.
Howell MD; Jones JF; Kisich KO; Streib JE; Gallo RL; Leung DY
J Immunol; 2004 Feb; 172(3):1763-7. PubMed ID: 14734759
[TBL] [Abstract][Full Text] [Related]
17. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.
Supajatura V; Ushio H; Nakao A; Akira S; Okumura K; Ra C; Ogawa H
J Clin Invest; 2002 May; 109(10):1351-9. PubMed ID: 12021251
[TBL] [Abstract][Full Text] [Related]
18. Lipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2.
Kang SS; Sim JR; Yun CH; Han SH
Arch Pharm Res; 2016 Nov; 39(11):1519-1529. PubMed ID: 27498542
[TBL] [Abstract][Full Text] [Related]
19. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression.
Yang CS; Shin DM; Kim KH; Lee ZW; Lee CH; Park SG; Bae YS; Jo EK
J Immunol; 2009 Mar; 182(6):3696-705. PubMed ID: 19265148
[TBL] [Abstract][Full Text] [Related]
20. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea.
Muto Y; Wang Z; Vanderberghe M; Two A; Gallo RL; Di Nardo A
J Invest Dermatol; 2014 Nov; 134(11):2728-2736. PubMed ID: 24844861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
